Market Research Report
LAMEA Implantable Cardiac Monitors Market Analysis (2017-2023)
|Published by||KBV Research||Product code||644796|
|Published||Content info||61 Pages
|LAMEA Implantable Cardiac Monitors Market Analysis (2017-2023)|
|Published: May 17, 2018||Content info: 61 Pages||
The Latin America, Middle East and Africa Implantable Cardiac Monitors Market would witness market growth of 9% CAGR during the forecast period (2017 - 2023).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device.
Technological advancements in cardiac monitoring devices in area of medical cardiology, improved diagnostics, ease of use, and increased adoption in both hospitals & homecare are key growth factors, which are driving the market growth. Additionally, rising awareness among users about devices and treatment options for cardiac disorders is expected to create lucrative opportunities for the market in the near future.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Implantable Cardiac Monitors market segments the market into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the Latin America, Middle East and Africa Implantable Cardiac Monitors Market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma inc., Thoratec Corporation St.(Jude Medical, LLC), Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.
List of Tables